DMN:FRA
Diamyd Medical AB
тВм┬ареж.режремрез
arrow_upward
+реж.резрен%(+реж.режрежрежрезреж) 1D
рдиреЛрднреЗрдореНрдмрд░ резрен, режрео:режрел:реирей GMT+рез · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMN...
Open
тВм┬ареж.режрем
High
тВм┬ареж.режрем
Low
тВм┬ареж.режрем
Mkt. cap
резрей.рекрео┬ардХрд░реЛрдб
Avg. vol.
реж.режреж
Volume
реж.режреж
52-wk high
тВм┬арез.реореж
52-wk low
тВм┬ареж.режрел
No. of employees
рекреи
Open
тВм┬ареж.режрем
High
тВм┬ареж.режрем
Low
тВм┬ареж.режрем
Mkt. cap
резрей.рекрео┬ардХрд░реЛрдб
Avg. vol.
реж.режреж
Volume
реж.режреж
52-wk high
тВм┬арез.реореж
52-wk low
тВм┬ареж.режрел
No. of employees
рекреи
News stories
From web sources and news partners
ChartMill
·
реиреп рдорд┐рдиреЗрдЯ рдкрд╣рд┐рд▓реЗ
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
FOREX.com
·
релрел рдорд┐рдиреЗрдЯ рдкрд╣рд┐рд▓реЗ
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Investor's Business Daily
·
рез рдШрдгреНрдЯрд╛ рдкрд╣рд┐рд▓реЗ
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Quartz
·
рез рдШрдгреНрдЯрд╛ рдкрд╣рд┐рд▓реЗ
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GADтВЖтВЕ, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Ume├е which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employeesрекреи
Foundedрезрепреорек
Headquarters-
SectorHealth Care
Industry-
Websitediamyd.com